Thomas Ramdahl
Director/Board Member at CLARITY PHARMACEUTICALS LTD
Net worth: 2 M $ as of 30/05/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Matthew Harris | M | - | 14 years | |
| Colin Biggin | M | - | 7 years | |
| Alan Taylor | M | - | - | |
| Tony Lahoutte | M | - |
Precirix NV
 Precirix NV Pharmaceuticals: MajorHealth Technology Precirix NV develops and distributes radio-immunotherapeutic drugs for cancer patients. The company was founded on October 14, 2014 by Jens De Vos, Ludwig Camusot, Nick Devoogdt, Geert Raes, Tony Lahoutte and Matthias Dhuyvetter and is headquartered in Brussels, Belgium. | 10 years |
| Ruth Devenyns | F | 59 |
Precirix NV
Precirix NV Pharmaceuticals: MajorHealth Technology Precirix NV develops and distributes radio-immunotherapeutic drugs for cancer patients. The company was founded on October 14, 2014 by Jens De Vos, Ludwig Camusot, Nick Devoogdt, Geert Raes, Tony Lahoutte and Matthias Dhuyvetter and is headquartered in Brussels, Belgium. | - |
| Geert Raes | M | - |
Precirix NV
Precirix NV Pharmaceuticals: MajorHealth Technology Precirix NV develops and distributes radio-immunotherapeutic drugs for cancer patients. The company was founded on October 14, 2014 by Jens De Vos, Ludwig Camusot, Nick Devoogdt, Geert Raes, Tony Lahoutte and Matthias Dhuyvetter and is headquartered in Brussels, Belgium. | 10 years |
| David Green | M | - | 2 years | |
| Jens de Vos | M | - |
Precirix NV
Precirix NV Pharmaceuticals: MajorHealth Technology Precirix NV develops and distributes radio-immunotherapeutic drugs for cancer patients. The company was founded on October 14, 2014 by Jens De Vos, Ludwig Camusot, Nick Devoogdt, Geert Raes, Tony Lahoutte and Matthias Dhuyvetter and is headquartered in Brussels, Belgium. | 10 years |
| Catherine Strong | F | - | - | |
| Robert Vickery | M | 53 | 5 years | |
| Robert Thomas | M | 79 | 3 years | |
| Mike Ironside | M | - | 4 years | |
| Anita Tunold | F | - |
Appsens AS
 Appsens AS Medical SpecialtiesHealth Technology Appsens AS is a Norwegian company that develops, produces, and distributes the heart sensor ECG247. The company is based in Lillesand, Norway. The technology behind ECG247 is the result of many years of research in technology and has extensive clinical documentation of usability and accuracy. The company's technology consists of advanced algorithms, cloud-based data processing, and the use of artificial intelligence. The company was founded in 2017, and the CEO is Tord Ytterdahl. | - |
| Ellen van Dam | M | - | 10 years | |
| Jeffrey Norenberg | M | - | 2 years | |
| Michaël Vlemmix | M | - |
Precirix NV
Precirix NV Pharmaceuticals: MajorHealth Technology Precirix NV develops and distributes radio-immunotherapeutic drugs for cancer patients. The company was founded on October 14, 2014 by Jens De Vos, Ludwig Camusot, Nick Devoogdt, Geert Raes, Tony Lahoutte and Matthias Dhuyvetter and is headquartered in Brussels, Belgium. | - |
| Jean-Louis Baudhuin | M | - |
Precirix NV
Precirix NV Pharmaceuticals: MajorHealth Technology Precirix NV develops and distributes radio-immunotherapeutic drugs for cancer patients. The company was founded on October 14, 2014 by Jens De Vos, Ludwig Camusot, Nick Devoogdt, Geert Raes, Tony Lahoutte and Matthias Dhuyvetter and is headquartered in Brussels, Belgium. | - |
| Shaemus Gleason | M | - | 3 years | |
| Harald Moræus Hanssen | M | - |
Appsens AS
Appsens AS Medical SpecialtiesHealth Technology Appsens AS is a Norwegian company that develops, produces, and distributes the heart sensor ECG247. The company is based in Lillesand, Norway. The technology behind ECG247 is the result of many years of research in technology and has extensive clinical documentation of usability and accuracy. The company's technology consists of advanced algorithms, cloud-based data processing, and the use of artificial intelligence. The company was founded in 2017, and the CEO is Tord Ytterdahl. | - |
| Chris Roberts | M | 70 | - | |
| Michelle Parker | F | - | 6 years | |
| Rosanne Elizabeth Robinson | F | - | - | |
| Ohad Hammer | M | - |
Precirix NV
Precirix NV Pharmaceuticals: MajorHealth Technology Precirix NV develops and distributes radio-immunotherapeutic drugs for cancer patients. The company was founded on October 14, 2014 by Jens De Vos, Ludwig Camusot, Nick Devoogdt, Geert Raes, Tony Lahoutte and Matthias Dhuyvetter and is headquartered in Brussels, Belgium. | 6 years |
| Morten Graugaard Døssing | M | - |
Precirix NV
Precirix NV Pharmaceuticals: MajorHealth Technology Precirix NV develops and distributes radio-immunotherapeutic drugs for cancer patients. The company was founded on October 14, 2014 by Jens De Vos, Ludwig Camusot, Nick Devoogdt, Geert Raes, Tony Lahoutte and Matthias Dhuyvetter and is headquartered in Brussels, Belgium. | 6 years |
| Lars Peder Fosse Fensli | M | 48 |
Appsens AS
Appsens AS Medical SpecialtiesHealth Technology Appsens AS is a Norwegian company that develops, produces, and distributes the heart sensor ECG247. The company is based in Lillesand, Norway. The technology behind ECG247 is the result of many years of research in technology and has extensive clinical documentation of usability and accuracy. The company's technology consists of advanced algorithms, cloud-based data processing, and the use of artificial intelligence. The company was founded in 2017, and the CEO is Tord Ytterdahl. | - |
| Jennifer Rosenthal | M | - | 5 years | |
| Marten Steen | M | 49 |
Precirix NV
Precirix NV Pharmaceuticals: MajorHealth Technology Precirix NV develops and distributes radio-immunotherapeutic drugs for cancer patients. The company was founded on October 14, 2014 by Jens De Vos, Ludwig Camusot, Nick Devoogdt, Geert Raes, Tony Lahoutte and Matthias Dhuyvetter and is headquartered in Brussels, Belgium. | - |
| Tord Ytterdahl | M | - |
Appsens AS
Appsens AS Medical SpecialtiesHealth Technology Appsens AS is a Norwegian company that develops, produces, and distributes the heart sensor ECG247. The company is based in Lillesand, Norway. The technology behind ECG247 is the result of many years of research in technology and has extensive clinical documentation of usability and accuracy. The company's technology consists of advanced algorithms, cloud-based data processing, and the use of artificial intelligence. The company was founded in 2017, and the CEO is Tord Ytterdahl. | - |
| Christina Takke | M | 54 |
Precirix NV
Precirix NV Pharmaceuticals: MajorHealth Technology Precirix NV develops and distributes radio-immunotherapeutic drugs for cancer patients. The company was founded on October 14, 2014 by Jens De Vos, Ludwig Camusot, Nick Devoogdt, Geert Raes, Tony Lahoutte and Matthias Dhuyvetter and is headquartered in Brussels, Belgium. | 6 years |
| Axel Bendvold | M | - |
Appsens AS
Appsens AS Medical SpecialtiesHealth Technology Appsens AS is a Norwegian company that develops, produces, and distributes the heart sensor ECG247. The company is based in Lillesand, Norway. The technology behind ECG247 is the result of many years of research in technology and has extensive clinical documentation of usability and accuracy. The company's technology consists of advanced algorithms, cloud-based data processing, and the use of artificial intelligence. The company was founded in 2017, and the CEO is Tord Ytterdahl. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Joanna Horobin | M | 69 | 7 years | |
| Per Anders Göte Samuelsson | M | 63 | 8 years | |
| Jan Hendrik Egberts | M | 65 | 4 years | |
| Øystein Moan | M | 65 |
University of Oslo
| 1 years |
| Rainer Boehm | M | 63 | 4 years | |
| Einar Christen Lange | M | 82 |
University of Oslo
| 3 years |
| Tone Bjørnov | F | 62 |
University of Oslo
| 2 years |
| Runar Sandanger | M | 67 |
University of Oslo
| 1 years |
| Siri Birgit Teigum | F | 63 |
University of Oslo
| 3 years |
| Leif W. Andersen | M | 68 |
Norwegian University of Science & Technology
| 4 years |
| Kjell Rusti | M | - |
University of Oslo
| 4 years |
| Geir Claussen | M | - |
University of Oslo
| 4 years |
| Øyvind Mork | M | 70 |
Norwegian University of Science & Technology
| 4 years |
| Inga Kaasen | M | 66 |
University of Oslo
| 1 years |
| Svein J. Ruud Johansen | M | - |
University of Oslo
| 3 years |
| Oern Stuge | M | 70 |
University of Oslo
| 6 years |
| Rolv Eitrem Heggenhougen | M | - |
University of Oslo
| 3 years |
| Arne Blix | M | 70 |
University of Oslo
| 3 years |
| Anders Christian Ryssdal | M | 69 |
University of Oslo
| 3 years |
| Kjersti Gravningen | F | - |
University of Oslo
| 4 years |
| Ivar Gimse | M | - |
University of Oslo
| 1 years |
| Jon Nicolaisen | M | 65 |
University of Oslo
| 4 years |
| Otto Svein Skjåstad | M | 66 |
Norwegian University of Science & Technology
| 4 years |
| Olav Jarlsby | M | - |
University of Oslo
| 3 years |
| Erik Skullerud | M | 55 | 1 years | |
| Jon Asmyr | M | - | - | |
| Eddie Berglund | M | - | - | |
| Svein Ove Bjørnestad | M | 69 |
Norwegian University of Science & Technology
| 1 years |
| Liv Monica Bargem Stubholt | F | 63 |
University of Oslo
| 3 years |
| Walter Hafslo Qvam | M | 71 |
Norwegian University of Science & Technology
| 1 years |
| Tore H. Halvorsen | M | 70 |
Norwegian University of Science & Technology
| 1 years |
| John Thuestad | M | 64 |
Norwegian University of Science & Technology
| 4 years |
| Trygve Arnesen | M | 66 |
Norwegian University of Science & Technology
| 1 years |
| Even Aas | M | 63 |
University of Oslo
| 4 years |
| Yngve Slyngstad | M | 62 |
University of Oslo
| 3 years |
| Arvid Grundekjøn | M | 69 |
University of Oslo
| 3 years |
| Olav Stokke | M | - |
Norwegian University of Science & Technology
| 1 years |
| Håkon O. Bugge | M | - |
University of Oslo
| 1 years |
| Marit Liland Sandvold | M | 66 |
Norwegian University of Science & Technology
| 4 years |
| Odd Gleditsch | M | - |
University of Oslo
| 3 years |
| Svein Ilebekk | M | 70 |
University of Oslo
| 1 years |
| Christian Andreas Beck | M | 68 |
University of Oslo
| 3 years |
| Camilla Jarlsby | F | 62 |
University of Oslo
| 3 years |
| Hilde Myrberg | F | 66 |
University of Oslo
| 3 years |
| Solveig Elisabeth Hellebust | M | 57 | 2 years | |
| Per Gisle Djupesland | M | 68 |
University of Oslo
| 3 years |
| Mimi Kristine Berdal | F | 65 |
University of Oslo
| 3 years |
| Liselott Kilaas | F | 65 |
University of Oslo
| 1 years |
| Kjetil Olsen | M | 64 |
Pronova BioPharma ASA
 Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | 9 years |
| Terje V. Arnesen | M | - |
University of Oslo
| 4 years |
| Terje Osmundsen | M | - |
University of Oslo
| 2 years |
| Tone Merete Østensen | F | - |
University of Oslo
| 3 years |
| Karin Judith Meyer-Rosberg | M | 58 | 3 years | |
| Tina Bønsdorff | F | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Norway | 59 | 70.24% |
| Australia | 15 | 17.86% |
| Belgium | 10 | 11.90% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Thomas Ramdahl
- Personal Network
